June 12, 2018
Chief leads off the show describing exactly what a tariff war with Canada would look like before commenting on President Trump’s North Korean summit. Joel Elconin of Benzinga breaks down the Belmont Stakes, comparing Justify’s Triple Crown with past champions. Kenny Polcari, Director of NYSE Floor Operations at O’Neil Securities and a contributor to CNBC, reflects on a huge trading day back in 1982 and how it’s affected his career ever since. Karl Denninger of Market Ticker discusses auto tariffs. Finally, John Neal of PTI Securities & Futures‘ Peoria, AZ office talks competition.
June 7, 2018
Denver-based labor attorney, Lou Michels, calls in for hour one to discuss networks’ decisions in firing outspoken employees before debating the requirement of standing for the National Anthem at sporting events. Fari Hamzei of Hamzei Analytics talks market timing. David Andalman of PTI Securities & Futures shares trading strategies before reflecting on the rise of $SBUX.
June 6, 2018
Kevin O’Neill calls in for hour one to talk market overreactions, $AMZN and much more. Russell Rhoads of CBOE is in-studio for hour two talking trading strategies, big government and technicals versus fundamentals.
June 5, 2018
Chief and Matty Weber lead off the show talking MLB Draft, the passing of Dwight Clark, and the history of multi-sport athletes. Joel Elconin of Benzinga talks markets before sharing a brief Belmont preview. Kenny Polcari, Director of NYSE Floor Operations at O’Neil Securities and a contributor to CNBC, talks tech stocks and how companies like $AAPL have changed our society for better or worse. Karl Denninger of Market Ticker digs in to the employment number before touching on Illinois’s pension crisis. Finally, John Neal of PTI Securities & Futures‘ Peoria, AZ office talks gambling, coffee and tariffs.
June 4, 2018
Chicago attorney Brendan Cournane is in-studio. Chief and Brendan welcome options guru and veteran floor trader, Frank Fahey, for hour one to discuss President Trump’s ‘I can pardon myself’ comments and much more. David Andalman of PTI Securities & Futures joins the guys to talk cancer research stocks, the managerial class and stock buybacks.